300: What Happens When Compassionate Leadership Intersects With Purpose - An Interview With John Crowley

In this riveting episode, we unravel the extraordinary story of John F. Crowley, Executive Chairman of Amicus and former CEO from 2005 to 2022. When two of his children were diagnosed with Pompe disease in 1998, a severe neuromuscular disorder, John's life took a profound turn.

Leaving his role at Bristol-Myers Squibb, he became an entrepreneurial force as the Co-founder, President, and CEO of Novazyme Pharmaceuticals, steering groundbreaking research that ultimately saved his children's lives. Acquired by Genzyme Corporation in 2001, John continued his impactful journey, shaping the development of a revolutionary drug for Pompe disease. 

This episode explores the fusion of compassionate leadership and purpose, shedding light on the resilience and empathy that have defined John Crowley's remarkable career.